The Valley Desk

NCT00868413 · Interventional trial

Study of ABT-263 When Administered in Combination With Either Fludarabine/Cyclophosphamide/Rituximab or Bendamustine/Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

Overall registry status Completed

Phase 1

Conditions Chronic Lymphocytic Leukemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov